化瘀止痛胶囊合脐止痛散配合治疗子宫腺肌病的临床研究.pdfVIP

化瘀止痛胶囊合脐止痛散配合治疗子宫腺肌病的临床研究.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
化瘀止痛胶囊合脐止痛散配合治疗子宫腺肌病的临床研究

The Clinical Research on the Effect of HuaYuZhiTong Capsule and FuQiZhiTong Powder in Treating Adenomyosis Speciality: Gynecology of TCM, The study of menstruation sickness and sterility Tutor: Professor Ye Qing Author: Zhang Jing Abstract Objective: Observe the clinical curative effect of HuaYuZhiTong Capsule combined with FuQiZhiTong Powder, which is applied to treat adenomyosis dysmenorrhea and explore its work mechanism. Methods: We totally observed 65 patients of adenomyosis and it was divided into two groups randomly. The treatment group take HuaYuZhiTong Capsule combined with FuQiZhiTong Powder, while the control group takes SanJie ZhenTong capsule and HuaJi, which are compared to observe their curative effects and impacts on CA125 、prostaglandin E2 and tumor necrosis factor - α. Results: After treatment, the dysmenorrhea level score of the two groups were obviously decreased (P0.05) but there were no significant differences between groups (P >0.05). The syndrome score of the treatment group has significant difference (P0.05 or P0.01) , while mostly of the control group was the same as before. The Uterine volume、CA125 and prostaglandin E2 of the treatment group is obviously decreased after treating, which has significant differences compared with its original level (P0.05 or P0.01) and the prostaglandin E2 of the control grouphas significant differences compared with its original level (P0.01). The tumor necrosis factor – α level of the treatment group is obviously decreased after treating, which has significant differences compared with its original level (P0.01) and the control group (P0.01). Conclusion: HuaYuZhiT

您可能关注的文档

文档评论(0)

canggu808866 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档